Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2020
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1En-Chi Hsu, Meghan A Rice, Abel Bermudez, et al.Cell|August 9, 2016
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerJustin M Drake, Evan O Paull, Nicholas A Graham, et al.Proceedings of the National Academy of Sciences of the United States of America|October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancerTanya Stoyanova, Mireille Riedinger, Shu Lin, et al.Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.Cell Reports. Medicine|March 4, 2022
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancerMeghan A Rice, Vineet Kumar, Dhanir Tailor, et al.Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.Pageof 7